Metraipolis › archive › dc_72249a647bbe
Blinatumomab demonstrates MRD eradication in MRD-positive/chemotherapy-delayed pediatric B-ALL and high response in relapsed/refractory cases: a multicenter… — Europe PMC PMID:41050705
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41050705
- DOI
- 10.3389/fimmu.2025.1607138
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T21:14:12.651Z
- SHA-256 of the archived text
38d110f710406abff9dc1434b9f70b6bd3f239e7ac6083d169ff3ce5ae1b8e81- Stable URL of this page
https://metraipolis.com/documento/dc_72249a647bbe
How to cite
Blinatumomab demonstrates MRD eradication in MRD-positive/chemotherapy-delayed pediatric B-ALL and high response in relapsed/refractory cases: a multicenter… — Europe PMC PMID:41050705 — Europe PMC (en), https://europepmc.org/article/MED/41050705 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72249a647bbe (Metraipolis archive dc_72249a647bbe, sha256 38d110f710406abff9dc1434b9f70b6bd3f239e7ac6083d169ff3ce5ae1b8e81)
BibTeX
@misc{dc72249a647bbe,
title = {Blinatumomab demonstrates MRD eradication in MRD-positive/chemotherapy-delayed pediatric B-ALL and high response in relapsed/refractory cases: a multicenter… — Europe PMC PMID:41050705},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41050705},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72249a647bbe; sha256 38d110f710406abff9dc1434b9f70b6bd3f239e7ac6083d169ff3ce5ae1b8e81},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41050705. Agents can read the archived copy with the MCP tool read_document.